Breaking News, Promotions & Moves

Daiichi Sankyo, Inc.

John P. Gargiulo has been appointed president and chief executive officer of Daiichi Sankyo, Inc. (DSI), the U.S. division of Daiichi Sankyo Co. Ltd.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

John P. Gargiulo has been appointed president and chief executive officer of Daiichi Sankyo, Inc. (DSI), the U.S. division of Daiichi Sankyo Co. Ltd. Mr. Gargiulo succeeds Joseph P. Pieroni, who is retiring after leading Daiichi’s U.S. commercial operations for the past 14 years. “John’s experiences within the pharmaceutical industry for the past 25 years have prepared him well for his new role and responsibility,” said Mr. Pieroni. “He has been instrumental in building and shaping the compan...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters